Thomas M. Rose

Partner

757.687.7715

More ways to contact Thomas M. Rose

Tom has helped U.S. and international businesses, issuers, and investment banks negotiate and close billions of dollars in cross-border financings and merger and acquisition transactions, which includes multiple deals recognized as the "Deal of the Year" in their respective industries. For Tom, teamwork is the essential ingredient for success in complex deals.

Sponsored Events

2026 Bloom Burton & Co. Healthcare Investor Conference
Overview
Representative Matters
Insights
Awards

Tom is an exceptionally experienced attorney who concentrates his practice on U.S. cross-border securities, merger and acquisition, and corporate law matters. With a particular focus on U.S.-Canada activity, every year he and his team advise clients with respect to financing and merger and acquisition transactions totaling billions of dollars – regularly landing them among the top performers on Thomson Reuters’ annual league tables and recently earning the “Impact Deal of the Year” Award for Canada from LMG North America and the “Pharmaceutical Deal of the Year” Atlas Award from Global M&A Network.

Tom’s services adapt and grow along with the needs of his clients. He represents U.S. and foreign issuers and investment banks in a broad range of public and private financings, including financings under the U.S.-Canada Multijurisdictional Disclosure System (MJDS), other cross-border public offerings, and U.S.-foreign private placements (including Rule 144A, Regulation D, and Regulation S offerings). Tom also advises U.S. and foreign issuers with respect to the securities and corporate law aspects of mergers and acquisition transactions of all types.

Tom counsels U.S. and foreign issuers in connection with initial listings on the New York Stock Exchange (NYSE), the NYSE American, and the Nasdaq Stock Market (NASDAQ). He also helps clients ensure compliance with ongoing U.S. reporting and corporate governance requirements under U.S. federal securities laws and exchange rules, and acts as a principal American liaison (PAL) on the over-the-counter (OTC) international markets.

Tom has provided U.S. corporate and securities law advice for the following recent representative transactions/matters:

Life Sciences

  • Ceapro Inc.
    Amalgamation with Aeterna Zentaris Inc. (CDN $75 million) (Impact Deal of the Year for Canada from LMG North America)
    Listing on Nasdaq Capital Market
  • Cardiol Therapeutics Inc.
    U.S. public offering of common shares (US $15.5 million)
    U.S. at-the-market offering (US $50 million)
    Offerings of units (US $50 million and CDN $25 million, respectively)
    Listing on NASDAQ Capital Market
  • Eupraxia
    Offering of preferred shares (CDN $44.5 million)
  • MindMedicine (MindMed) Inc.
    Offering of units (CDN $20 million)
    Listing on NASDAQ Capital Market
  • Medicenna Therapeutics Corp.
    PIPE offering (CDN $20 million)
    Offering of common shares (CDN $35 million)
    U.S. at-the-market offering (US $25 million)
    Listing on NASDAQ Capital Market
  • Bellus Health Inc.
    U.S. initial public offering of common shares (US $80 million)
    U.S. public offering of common shares (CDN $56 million)
    Listing on NASDAQ Global Market
  • IMV Inc.
    U.S. public offerings of common shares (US $25 million and CDN $30 million, respectively)
    Offerings of common shares (CDN $25 million, CDN $14.5 million, and CDN $10 million, respectively)
    U.S. at-the-market offerings (US $50 million and US $30 million)
    Listing on NASDAQ Capital Market
  • Cynapsus Therapeutics Inc.
    Acquisition by Sunovion Pharmaceuticals Inc. (CDN $830 million)
    U.S. initial public offering of common shares (US $72.5 million)
    Offerings of common shares (CDN $21 million) and units (CDN $25 million and CDN $10 million, respectively)
    Listing on NASDAQ Global Market
  • Tribute Pharmaceuticals Canada Inc.
    U.S. tax inversion transaction with Pozen Inc. to create Aralez Pharmaceuticals Inc. (The Americas M&A Atlas Awards, Pharma & Devices Deal of the Year)
    Offerings of common shares (US $75 million and CDN $12 million), convertible debentures (US $75 million) and units (CDN $26 million)
    Listing on OTCQX International
  • CannTrust Inc.
    U.S. Initial Public Offering (US $175 million)
    Listing on Nasdaq Global Market

Technology

  • Voyager Digital Inc.
    Offerings of common shares (CDN $46 million, CDN $100 million, and CDN $75 million, respectively)
  • VIQ Solutions, Inc.
    Listing on NASDAQ Capital Market
    Offering of common shares (CDN $20 million)
  • Boohoo.com Inc.
    Offerings of ordinary shares (£200 million and £150 million, respectively)
  • DHX Media Inc.
    U.S. public offering of common shares (CDN $75 million)
    Offerings of common shares (CDN $40 million and CDN $135 million, respectively), subscription receipts (CDN $140 million) and rights (CDN $60 million)
    Listing on NASDAQ Global Select Market
  • Catamaran Corp.
    U.S. initial public offering of common shares (US $40 million)
    Listing on NASDAQ Global Select Market

Energy and Renewables

  • Tiaga Motors Inc.
    De-SPAC transaction and offering of nonvoting shares (CDN $100 million)
  • Innergex Renewable Energy Inc
    Offerings of common shares (CDN $250 million and CDN $172.5 million, respectively)
  • Tullow Oil Corp.
    Rights offering (£607 million) (US $750 million)
    Acquisition of interest in Hyperdynamics Corp.’s oil and gas interest in Guinea
  • Alterra Power Corp.
    Acquisition by Innergex Renewable Energy Inc. (CDN $1.1 billion) (Renewable Energy Deal of the Year, The Americas M&A Atlas Awards, 2018)
    Merger with Plutonic Power Corporation (CDN $600 million)
    Offerings of common shares (CDN $70 million, CDN $45 million, and CDN $100 million, respectively)

Mining

  • Karora Resources Inc.
    Amalgamtion with Westgold Resources Limited (A $2.5 billion)
  • Invanhoe Mines Ltd.
    Investment in I-Pulse Inc. (US $80 million)
  • Appian Capital Advisory LLP
    Acquisition of Atlantic Strategic Minerals Inc. (Value Not Disclosed)
  • Impala Platinum Holdings Limited
    Offering of ordinary shares (ZAR $4 billion (US $300 million))
  • Enirgi Group Corp.
    Going-private transaction involving Natural Resources USA Corp.
  • Northern Orion Resources Inc.
    Business combination with Yamana Gold Inc. and Meridian Gold Inc. (CDN $8.1 billion)
  • Aur Resources Inc.
    Tender offer by Teck Cominco Ltd. (CDN $4 billion)

Underwriter/Agent Representations

Tom regularly acts for underwriters and agents on public and private offerings, including the following:

  • Raymond James Ltd.
    Offering of common shares for Profound Medical Inc. (US $40 million)
    Offering of common shares for Westfire Energy Ltd. (CDN $40 million)
    Offerings of common shares and subscription receipts for GasFrac Energy Services Inc. (CDN $95 million, CDN $65 million, and CDN $40 million, respectively)
  • BMO Capital Markets
    Offering of common shares and subscription receipts for Allied Gold Corp. (US $270 million)
    Offering of common shares for Base Carbon Corp (CDN $50 million)
    Offering of trust units for Chartwell Retirement Residences (CDN $200 million)
    Offering of subscription receipts for Mandalay Resources Corporation (CDN $45 million)
  • National Bank Financial Inc.
    U.S. public offering for Gold Royalty Corp. (US $35 million)
    U.S. at-the-market offering for I-80 GOLD CORP. (US $50 million)
    Offering of units for Sulliden Gold Corp. (CDN $40 million)
  • Bloom Burton Securities Inc.
    Offering of common shares for Satellos Biosciences Inc. (US $40 million)
    U.S. PIPE offering of common shares for Cybin Inc. (US $150 million)
    Offering of common shares for Field Trip Health Ltd. (CDN $95 million)
    Offering of units for Appili Therapeutics Inc. (CDN $20 million)
  • Scotiabank
    Offering of common shares for Mineros SA (US $34.5 million)
    Offering of common shares for Rio2 Limited (CDN $37.5 million)
    Offering of common shares for OceanaGold Corporation (CDN $150 million)
    Offering of special warrants (CDN $50 million) and subscription receipts (CDN $85 million) for Caldas Gold Corp.
    Offering of convertible debentures for San Gold Corp. (CDN $50 million)
  • Stifel Nicolaus Canada Inc.
    U.S. public offering for The Valens Company Inc. (CDN $32.5 million)
    Offering of units for Else Nutrition Holdings Inc. (CDN $20 million)
  • Macquarie Capital Markets Canada Ltd.
    U.S. public offerings for Gold Standard Ventures Corp. (CDN $11 million and CDN $7 million)
    Offering of common shares for TransGlobe Energy Corp. (CDN $75 million)
    Offering of common shares for Crew Energy Inc. (CDN $100 million)
  • Canaccord Genuity Corp.
    Offering of units for Champignon Brands (CDN $15 million)
    Offering of subscription receipts for Small Pharma Ltd. (CDN $60 million)
  • Cormark Securities Inc.
    U.S. public offering for Western Copper and Gold Corporation (CDN $30 million)
    Offering of common shares for Antrim Energy Inc. (CDN $50 million)
    U.S. public offering of common shares for Vista Gold Corp. (US $32 million)
  • Haywood Securities Inc.
    Offerings of special warrants for Midas Gold Corp. (CDN $45 million and CDN $40 million, respectively)
    U.S. at-the-market offering and U.S. public offerings of units for Uranerz Energy Corp. (US $20 million, US $10 million, and CDN $12 million, respectively)
  • Desjardins Capital Markets
    Offering of common shares for Aya Gold & Silver Inc. (CDN $70 million)

 

League Tables

Bloomberg | Global Legal Adviser League Tables | Q3 2025

Canada Equity Offerings: Legal Adviser – Issuer Ranked by Deal Count

  • #2 Ranked Firm (#1 U.S.-based firm) 

Canada Equity Offerings: Legal Adviser – Issuer Ranked by Volume

  • #7 Ranked Firm (#3 U.S.-based firm) 

Canada Equity Offerings: Legal Adviser – Manager Ranked by Deal Count

  • #7 Ranked Firm (#1 U.S.-based firm) 

Canada Equity IPO: Legal Adviser – Manager Ranked by Volume

  • #3 Ranked Firm (#1 U.S.-based firm) 

Canada Equity IPO: Legal Adviser – Manager Ranked by Deal Count

  • #2 Ranked Firm (#1 U.S.-based firm) 

Canada Equity & Equity Linked: Legal Adviser – Issuer Ranked by Deal Count

  • #2 Ranked Firm (#1 U.S.-based firm) 

Canada Equity & Equity Linked: Legal Adviser – Manager Ranked by Deal Count

  • #7 Ranked Firm (#1 U.S.-based firm) 

Canada Equity, Equity Linked & Preferred: Legal Adviser – Issuer Ranked by Volume

  • #9 Ranked Firm (#4 U.S.-based firm) 

Canada Equity, Equity Linked & Preferred: Legal Adviser – Issuer Ranked by Deal Count

  • #2 Ranked Firm (#1 U.S.-based firm) 

Canada Equity, Equity Linked & Preferred: Legal Adviser – Manager Ranked by Deal Count

  • #8 Ranked Firm (#4 U.S.-based firm) 

LSEG | Global Capital Markets Legal Review | Q3 2025

Canada Equity & Equity Related – Issuer Legal Counsel (Number of Deals)

  • #3 ranked firm (#1 U.S.-based firm)
  • LMG Life Sciences, Impact Deal of the Year Canada (2024)
  • Best Lawyers in America®: Securities/Capital Markets Law (2013-2026)
  • Virginia Super Lawyers (2013-2022)
  • Virginia Legal Elite, Business Law (2013-2015, 2018)
Overview

Tom is an exceptionally experienced attorney who concentrates his practice on U.S. cross-border securities, merger and acquisition, and corporate law matters. With a particular focus on U.S.-Canada activity, every year he and his team advise clients with respect to financing and merger and acquisition transactions totaling billions of dollars – regularly landing them among the top performers on Thomson Reuters’ annual league tables and recently earning the “Impact Deal of the Year” Award for Canada from LMG North America and the “Pharmaceutical Deal of the Year” Atlas Award from Global M&A Network.

Tom’s services adapt and grow along with the needs of his clients. He represents U.S. and foreign issuers and investment banks in a broad range of public and private financings, including financings under the U.S.-Canada Multijurisdictional Disclosure System (MJDS), other cross-border public offerings, and U.S.-foreign private placements (including Rule 144A, Regulation D, and Regulation S offerings). Tom also advises U.S. and foreign issuers with respect to the securities and corporate law aspects of mergers and acquisition transactions of all types.

Tom counsels U.S. and foreign issuers in connection with initial listings on the New York Stock Exchange (NYSE), the NYSE American, and the Nasdaq Stock Market (NASDAQ). He also helps clients ensure compliance with ongoing U.S. reporting and corporate governance requirements under U.S. federal securities laws and exchange rules, and acts as a principal American liaison (PAL) on the over-the-counter (OTC) international markets.

Representation Matters

Tom has provided U.S. corporate and securities law advice for the following recent representative transactions/matters:

Life Sciences

  • Ceapro Inc.
    Amalgamation with Aeterna Zentaris Inc. (CDN $75 million) (Impact Deal of the Year for Canada from LMG North America)
    Listing on Nasdaq Capital Market
  • Cardiol Therapeutics Inc.
    U.S. public offering of common shares (US $15.5 million)
    U.S. at-the-market offering (US $50 million)
    Offerings of units (US $50 million and CDN $25 million, respectively)
    Listing on NASDAQ Capital Market
  • Eupraxia
    Offering of preferred shares (CDN $44.5 million)
  • MindMedicine (MindMed) Inc.
    Offering of units (CDN $20 million)
    Listing on NASDAQ Capital Market
  • Medicenna Therapeutics Corp.
    PIPE offering (CDN $20 million)
    Offering of common shares (CDN $35 million)
    U.S. at-the-market offering (US $25 million)
    Listing on NASDAQ Capital Market
  • Bellus Health Inc.
    U.S. initial public offering of common shares (US $80 million)
    U.S. public offering of common shares (CDN $56 million)
    Listing on NASDAQ Global Market
  • IMV Inc.
    U.S. public offerings of common shares (US $25 million and CDN $30 million, respectively)
    Offerings of common shares (CDN $25 million, CDN $14.5 million, and CDN $10 million, respectively)
    U.S. at-the-market offerings (US $50 million and US $30 million)
    Listing on NASDAQ Capital Market
  • Cynapsus Therapeutics Inc.
    Acquisition by Sunovion Pharmaceuticals Inc. (CDN $830 million)
    U.S. initial public offering of common shares (US $72.5 million)
    Offerings of common shares (CDN $21 million) and units (CDN $25 million and CDN $10 million, respectively)
    Listing on NASDAQ Global Market
  • Tribute Pharmaceuticals Canada Inc.
    U.S. tax inversion transaction with Pozen Inc. to create Aralez Pharmaceuticals Inc. (The Americas M&A Atlas Awards, Pharma & Devices Deal of the Year)
    Offerings of common shares (US $75 million and CDN $12 million), convertible debentures (US $75 million) and units (CDN $26 million)
    Listing on OTCQX International
  • CannTrust Inc.
    U.S. Initial Public Offering (US $175 million)
    Listing on Nasdaq Global Market

Technology

  • Voyager Digital Inc.
    Offerings of common shares (CDN $46 million, CDN $100 million, and CDN $75 million, respectively)
  • VIQ Solutions, Inc.
    Listing on NASDAQ Capital Market
    Offering of common shares (CDN $20 million)
  • Boohoo.com Inc.
    Offerings of ordinary shares (£200 million and £150 million, respectively)
  • DHX Media Inc.
    U.S. public offering of common shares (CDN $75 million)
    Offerings of common shares (CDN $40 million and CDN $135 million, respectively), subscription receipts (CDN $140 million) and rights (CDN $60 million)
    Listing on NASDAQ Global Select Market
  • Catamaran Corp.
    U.S. initial public offering of common shares (US $40 million)
    Listing on NASDAQ Global Select Market

Energy and Renewables

  • Tiaga Motors Inc.
    De-SPAC transaction and offering of nonvoting shares (CDN $100 million)
  • Innergex Renewable Energy Inc
    Offerings of common shares (CDN $250 million and CDN $172.5 million, respectively)
  • Tullow Oil Corp.
    Rights offering (£607 million) (US $750 million)
    Acquisition of interest in Hyperdynamics Corp.’s oil and gas interest in Guinea
  • Alterra Power Corp.
    Acquisition by Innergex Renewable Energy Inc. (CDN $1.1 billion) (Renewable Energy Deal of the Year, The Americas M&A Atlas Awards, 2018)
    Merger with Plutonic Power Corporation (CDN $600 million)
    Offerings of common shares (CDN $70 million, CDN $45 million, and CDN $100 million, respectively)

Mining

  • Karora Resources Inc.
    Amalgamtion with Westgold Resources Limited (A $2.5 billion)
  • Invanhoe Mines Ltd.
    Investment in I-Pulse Inc. (US $80 million)
  • Appian Capital Advisory LLP
    Acquisition of Atlantic Strategic Minerals Inc. (Value Not Disclosed)
  • Impala Platinum Holdings Limited
    Offering of ordinary shares (ZAR $4 billion (US $300 million))
  • Enirgi Group Corp.
    Going-private transaction involving Natural Resources USA Corp.
  • Northern Orion Resources Inc.
    Business combination with Yamana Gold Inc. and Meridian Gold Inc. (CDN $8.1 billion)
  • Aur Resources Inc.
    Tender offer by Teck Cominco Ltd. (CDN $4 billion)

Underwriter/Agent Representations

Tom regularly acts for underwriters and agents on public and private offerings, including the following:

  • Raymond James Ltd.
    Offering of common shares for Profound Medical Inc. (US $40 million)
    Offering of common shares for Westfire Energy Ltd. (CDN $40 million)
    Offerings of common shares and subscription receipts for GasFrac Energy Services Inc. (CDN $95 million, CDN $65 million, and CDN $40 million, respectively)
  • BMO Capital Markets
    Offering of common shares and subscription receipts for Allied Gold Corp. (US $270 million)
    Offering of common shares for Base Carbon Corp (CDN $50 million)
    Offering of trust units for Chartwell Retirement Residences (CDN $200 million)
    Offering of subscription receipts for Mandalay Resources Corporation (CDN $45 million)
  • National Bank Financial Inc.
    U.S. public offering for Gold Royalty Corp. (US $35 million)
    U.S. at-the-market offering for I-80 GOLD CORP. (US $50 million)
    Offering of units for Sulliden Gold Corp. (CDN $40 million)
  • Bloom Burton Securities Inc.
    Offering of common shares for Satellos Biosciences Inc. (US $40 million)
    U.S. PIPE offering of common shares for Cybin Inc. (US $150 million)
    Offering of common shares for Field Trip Health Ltd. (CDN $95 million)
    Offering of units for Appili Therapeutics Inc. (CDN $20 million)
  • Scotiabank
    Offering of common shares for Mineros SA (US $34.5 million)
    Offering of common shares for Rio2 Limited (CDN $37.5 million)
    Offering of common shares for OceanaGold Corporation (CDN $150 million)
    Offering of special warrants (CDN $50 million) and subscription receipts (CDN $85 million) for Caldas Gold Corp.
    Offering of convertible debentures for San Gold Corp. (CDN $50 million)
  • Stifel Nicolaus Canada Inc.
    U.S. public offering for The Valens Company Inc. (CDN $32.5 million)
    Offering of units for Else Nutrition Holdings Inc. (CDN $20 million)
  • Macquarie Capital Markets Canada Ltd.
    U.S. public offerings for Gold Standard Ventures Corp. (CDN $11 million and CDN $7 million)
    Offering of common shares for TransGlobe Energy Corp. (CDN $75 million)
    Offering of common shares for Crew Energy Inc. (CDN $100 million)
  • Canaccord Genuity Corp.
    Offering of units for Champignon Brands (CDN $15 million)
    Offering of subscription receipts for Small Pharma Ltd. (CDN $60 million)
  • Cormark Securities Inc.
    U.S. public offering for Western Copper and Gold Corporation (CDN $30 million)
    Offering of common shares for Antrim Energy Inc. (CDN $50 million)
    U.S. public offering of common shares for Vista Gold Corp. (US $32 million)
  • Haywood Securities Inc.
    Offerings of special warrants for Midas Gold Corp. (CDN $45 million and CDN $40 million, respectively)
    U.S. at-the-market offering and U.S. public offerings of units for Uranerz Energy Corp. (US $20 million, US $10 million, and CDN $12 million, respectively)
  • Desjardins Capital Markets
    Offering of common shares for Aya Gold & Silver Inc. (CDN $70 million)

 

League Tables

Bloomberg | Global Legal Adviser League Tables | Q3 2025

Canada Equity Offerings: Legal Adviser – Issuer Ranked by Deal Count

  • #2 Ranked Firm (#1 U.S.-based firm) 

Canada Equity Offerings: Legal Adviser – Issuer Ranked by Volume

  • #7 Ranked Firm (#3 U.S.-based firm) 

Canada Equity Offerings: Legal Adviser – Manager Ranked by Deal Count

  • #7 Ranked Firm (#1 U.S.-based firm) 

Canada Equity IPO: Legal Adviser – Manager Ranked by Volume

  • #3 Ranked Firm (#1 U.S.-based firm) 

Canada Equity IPO: Legal Adviser – Manager Ranked by Deal Count

  • #2 Ranked Firm (#1 U.S.-based firm) 

Canada Equity & Equity Linked: Legal Adviser – Issuer Ranked by Deal Count

  • #2 Ranked Firm (#1 U.S.-based firm) 

Canada Equity & Equity Linked: Legal Adviser – Manager Ranked by Deal Count

  • #7 Ranked Firm (#1 U.S.-based firm) 

Canada Equity, Equity Linked & Preferred: Legal Adviser – Issuer Ranked by Volume

  • #9 Ranked Firm (#4 U.S.-based firm) 

Canada Equity, Equity Linked & Preferred: Legal Adviser – Issuer Ranked by Deal Count

  • #2 Ranked Firm (#1 U.S.-based firm) 

Canada Equity, Equity Linked & Preferred: Legal Adviser – Manager Ranked by Deal Count

  • #8 Ranked Firm (#4 U.S.-based firm) 

LSEG | Global Capital Markets Legal Review | Q3 2025

Canada Equity & Equity Related – Issuer Legal Counsel (Number of Deals)

  • #3 ranked firm (#1 U.S.-based firm)
Insights

Sponsored Events

2026 Bloom Burton & Co. Healthcare Investor Conference

Articles + Publications

Update: SEC Exempts Directors and Officers of Certain FPIs From Section 16 Reporting

Articles + Publications

Update: US Insider Reporting Requirements Coming for Directors and Officers of Foreign Private Issuers

Firm News

Troutman Pepper Locke Again Earns Top Rankings on Canada Capital Markets League Tables

See all insights from Thomas M. Rose

Awards
  • LMG Life Sciences, Impact Deal of the Year Canada (2024)
  • Best Lawyers in America®: Securities/Capital Markets Law (2013-2026)
  • Virginia Super Lawyers (2013-2022)
  • Virginia Legal Elite, Business Law (2013-2015, 2018)

Top areas of focus

  • Member, International Bar Association, officer, Securities and Capital Markets Committee; chair of the Conferences Subcommittee; vice chair of the Conferences Subcommittee (2025)
  • New Hampshire Bar Association
  • American Bar Association
  • District Columbia Bar Association

Education

  • The George Washington University, J.D., 1999
  • Northwestern University, B.A., 1994

Bar Admissions

  • District of Columbia
  • New Hampshire
  • Virginia

Tom is a frequent speaker on U.S. corporate and securities laws matters. His recent speaking engagements include, but are not limited to, the following:

  • Speaker, Foreign Issuer Seminar, January 27, 2026.
  • Speaker, “Canada – Benefits and Paths to Pursuing a US Dual Listing,” The 37th Annual ROTH Conference, March 16-18, 2025.
  • Speaker, “Preparing Your Company for an Exit,” MassBio General Counsel Roundtable, June 20, 2024.
  • Speaker, “CANADA – Cross Listing Discussion,” 36th Annual ROTH Conference, March 19, 2024.
  • Speaker, 36th Annual ROTH Conference, March 17-19, 2024.
  • Speaker, “Foreign Private Issuers: Qualifying for Valuable Exemptions From SEC Reporting Requirements,” Strafford Webinars, May 10, 2017.
  • Speaker, “BLG Global Access to Capital Seminar Series,” Toronto, several dates.
  • Speaker, “Extractive Sector Transparency Reporting,” Rocky Mountain Mineral Law Institute, Squaw Valley, CA, July 22, 2016.
  • Speaker, “U.S. Securities Laws Update,” Canadian Bar Association – Alberta Branch, Calgary, January 26, 2016.
  • Speaker, “U.S. Cross Border Offerings,” CLS Education Sub-Committee Breakfast Seminar, Toronto, February 19, 2015.
  • Speaker, “U.S. Securities Laws Update,” Canadian Bar Association – Alberta Branch, Calgary, January 21, 2015.
  • Speaker, “Sponsor Panel Discussion,” Bloom Burton & Co. Healthcare Investor Conference, Toronto, July 17, 2014.